EPG logo
/api/v1/ui-configs/resources/ClientLogo.png
Welcome to EnvisionOne
or
Home
Expanded Access Program
The Envision Pharma Group Expanded Access Program portal is now open for investigational drug requests, application status inquiries, and project updates. Please remember that our normal processing time for a new investigational drug request is a minimum of 8 weeks.Prior to submitting your investigational drug request, please be sure to review our Additional Information sections below. Also, at the top of the page, you will want to familiarize yourself with our “FAQs” and “How to Apply” documents.
For technical assistance with the Expanded Access Program management system, please call us toll-free at (866) 257-0272, or email us at vtsupport@envisionpharma.com
For any questions related to the process and/or submissions please email Envision’s Expanded Access Program Department at info@envisionpharma.com.
Envision Pharma Group is committed to supporting Expanded Access Programs outside our organization that aligns with our goal of advancing the development of medicine to improve the health or quality of life of patients. We may provide investigational product(s) to both Named Patient Program (NPP) and Managed Access Program (MAP) which comply with all applicable guidelines and fall within our areas of medical interest.
We currently support Expanded Access Programs within the following areas of medical interest to our company: Chronic Migraine Diabetes Immuno-oncology Medical Aesthetics Neurology Ophthalmology - Chronic Dry Eye, Glaucoma, Retinal Disease Urology - Overactive Bladder, Prostate Cancer Consider checking back at another time if you do not see the therapeutic or disease area related to your study.
Additional resources regarding Expanded Access Programs include but are not limited to: FDA.gov ClinicalTrials.gov EMA.europa.eu HC-SC.GC.ca ICH.org MHLW.go.jp/ NIH.gov
Contact us
Phone Number
(888) 555-2020
Email address
support@ets.com
helpdesk@envisionpharma.com
© 2024 Envision Pharma Inc. “Envision Pharma Group”, “Envision Technology Solutions” are registered trademarks or trademarks of Envision Pharma Inc or its affiliate/group companies. All rights reserved.